Atea Pharmaceuticals, Inc.
AVIR
$3.63
$0.0952.69%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 379.71M | 425.44M | 454.72M | 482.81M | 502.21M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.89M | 8.27M | 7.63M | 4.09M | 4.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 385.60M | 433.71M | 462.36M | 486.91M | 506.37M |
|
|
|||||
| Total Current Assets | 385.60M | 433.71M | 462.36M | 486.91M | 506.37M |
| Net Property, Plant & Equipment | 1.61M | 1.86M | 2.12M | 2.37M | 2.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.39M | 4.39M | 197.00K | 1.68M | 1.40M |
| Total Assets | 391.61M | 439.96M | 464.67M | 490.96M | 510.38M |
|
|
|||||
| Total Accounts Payable | 8.84M | 7.39M | 4.46M | 5.79M | 5.47M |
| Total Accrued Expenses | 10.45M | 13.55M | 13.35M | 18.62M | 20.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 821.00K | 811.00K | 800.00K | 790.00K | 780.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.12M | 21.75M | 18.60M | 25.19M | 26.62M |
|
|
|||||
| Total Current Liabilities | 20.12M | 21.75M | 18.60M | 25.19M | 26.62M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 425.00K | 634.00K | 842.00K | 1.05M | 1.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.65M | 6.50M | 6.36M | 6.20M | 6.05M |
| Total Liabilities | 27.19M | 28.88M | 25.80M | 32.44M | 33.91M |
|
|
|||||
| Common Stock & APIC | 800.03M | 809.46M | 802.85M | 788.56M | 776.28M |
| Retained Earnings | -435.65M | -398.49M | -364.22M | -330.68M | -299.53M |
| Treasury Stock & Other | 37.00K | 118.00K | 233.00K | 641.00K | -280.00K |
| Total Common Equity | 364.42M | 411.08M | 438.87M | 458.52M | 476.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 364.42M | 411.08M | 438.87M | 458.52M | 476.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 364.42M | 411.08M | 438.87M | 458.52M | 476.47M |
|
|
|||||